Who is this for?
Built for teams that need faster, reliable interpretation.GeneGenius is designed for teams who need faster, more reliable genomic interpretation.
Clinical Genomics Labs
CLIA-certified labs seeking faster, consistent interpretation.CLIA-certified and research laboratories seeking faster, more consistent variant interpretation workflows.
Hospital Genomics Programs
Health systems scaling genomics with lean bioinformatics teams.Health systems building or scaling clinical genomics services with limited bioinformatics staff.
Oncology Diagnostics Teams
Tumor boards and oncology teams interpreting variants.Molecular tumor boards and precision oncology teams interpreting somatic and germline variants.
Rare Disease Research Groups
Researchers analyzing exomes and genomes for rare disease.Academic and clinical researchers analyzing whole-exome and whole-genome sequencing for rare disease diagnosis.
Where genomic interpretation
drives decisions
Structured interpretation that drives clinical decisions.From rare disease diagnostics to precision oncology, structured AI‑driven interpretation supports confident clinical action.
Diagnostic Clarity
Faster rare disease interpretation with evidence-backed clarity.Accelerate the interpretation of variants in rare disease cases. Reduce uncertainty by synthesizing evidence from literature, functional studies, and clinical databases to support diagnostic decisions.
Therapy Relevance
Connect tumor variants to actionable therapies and trials.Identify actionable variants linked to targeted therapies, clinical trials, and treatment guidelines. Connect tumor genomics to evidence based therapeutic options.
Treatment Response
Pharmacogenomic insights for medication selection and dosing.Interpret pharmacogenomic variants that affect drug metabolism and efficacy. Align findings with CPIC guidelines to support medication selection and dosing decisions.
PharmGKB